Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Nov;104(3):726–730. doi: 10.1111/j.1476-5381.1991.tb12495.x

Effects of flecainide on isolated vascular smooth muscles of rat.

F Pérez-Vizcaino 1, J Duarte 1, J Tamargo 1
PMCID: PMC1908218  PMID: 1797332

Abstract

1. The inhibitory effects of flecainide were studied on contractile responses in rat isolated aortae and caudal artery and on spontaneous mechanical activity in portal vein segments. 2. In rat isolated aorta flecainide, 10(-6) M-5 x 10(-4) M, inhibited in a dose-dependent manner the contractile responses induced by high K (80 mM) and noradrenaline (NA, 10(-5) M). These inhibitory actions were observed when flecainide was added before or after the induced contractions and were similar in aortae with or without endothelium. 3. Contractile responses induced by addition of Ca to Ca-free high-K solution were also dose-dependently inhibited by flecainide (IC50 = 2.5 +/- 0.3 x 10(-5) M). Moreover, flecainide inhibited the contractile responses elicited by NA in rings incubated in Ca-free solution. 4. Flecainide also inhibited the spontaneous mechanical activity in portal vein segments (IC50 = 6.5 +/- 0.9 x 10(-5) M). 5. Flecainide, 10(-4) M, inhibited 45Ca uptake stimulated by high K or NA without altering 45Ca uptake in resting aortae. 6. These results indicated that in rat isolated aortae, caudal arteries and portal veins, flecainide inhibited Ca entry through voltage-operated channels and NA-induced Ca uptake as well as Ca release from intracellular stores, thus decreasing the availability of intracellular free Ca required for vascular smooth muscle contraction.

Full text

PDF
726

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Stewart J. R., Perry B. A., Van Hamersveld D. D., Johnson T. A., Conard G. J., Chang S. F., Kvam D. C., Pitt B. Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med. 1981 Aug 27;305(9):473–477. doi: 10.1056/NEJM198108273050901. [DOI] [PubMed] [Google Scholar]
  2. Anno T., Hondeghem L. M. Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery. Circ Res. 1990 Mar;66(3):789–803. doi: 10.1161/01.res.66.3.789. [DOI] [PubMed] [Google Scholar]
  3. Bao J. X., Eriksson I. E., Stjärne L. Neurotransmitters and pre- and post-junctional receptors involved in the vasoconstrictor response to sympathetic nerve stimulation in rat tail artery. Acta Physiol Scand. 1990 Dec;140(4):467–479. doi: 10.1111/j.1748-1716.1990.tb09023.x. [DOI] [PubMed] [Google Scholar]
  4. Barrigón S., Tamargo J. The effect of oxytocin on contractile responses and 45Ca movements in rat isolated aortic strips. Br J Pharmacol. 1986 Apr;87(4):763–770. doi: 10.1111/j.1476-5381.1986.tb14595.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  6. Campbell T. J. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res. 1983 Jun;17(6):344–352. doi: 10.1093/cvr/17.6.344. [DOI] [PubMed] [Google Scholar]
  7. Campbell T. J. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):291–296. doi: 10.1097/00005344-198303000-00021. [DOI] [PubMed] [Google Scholar]
  8. Carrón R., Pérez-Vizcaino F., Delpón E., Tamargo J. Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle. Br J Pharmacol. 1991 Jun;103(2):1453–1457. doi: 10.1111/j.1476-5381.1991.tb09810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cauvin C., Loutzenhiser R., Van Breemen C. Mechanisms of calcium antagonist-induced vasodilation. Annu Rev Pharmacol Toxicol. 1983;23:373–396. doi: 10.1146/annurev.pa.23.040183.002105. [DOI] [PubMed] [Google Scholar]
  10. Delpón E., Valenzuela C., Tamargo J. Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres. Br J Pharmacol. 1991 Jun;103(2):1411–1416. doi: 10.1111/j.1476-5381.1991.tb09803.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Deth R., van Breemen C. Relative contributions of Ca2+ influx and cellular Ca2+ release during drug induced activation of the rabbit aorta. Pflugers Arch. 1974 Apr 4;348(1):13–22. doi: 10.1007/BF00587735. [DOI] [PubMed] [Google Scholar]
  12. Duff H. J., Roden D. M., Maffucci R. J., Vesper B. S., Conard G. J., Higgins S. B., Oates J. A., Smith R. F., Woosley R. L. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol. 1981 Dec;48(6):1133–1140. doi: 10.1016/0002-9149(81)90331-3. [DOI] [PubMed] [Google Scholar]
  13. Ebeigbe A. B., Aloamaka C. P. Mechanism of hydralazine-induced relaxation of arterial smooth muscle. Cardiovasc Res. 1985 Jul;19(7):400–405. doi: 10.1093/cvr/19.7.400. [DOI] [PubMed] [Google Scholar]
  14. Godfraind T. Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries. J Pharmacol Exp Ther. 1983 Feb;224(2):443–450. [PubMed] [Google Scholar]
  15. Godfraind T., Kaba A. Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle. Br J Pharmacol. 1969 Jul;36(3):549–560. doi: 10.1111/j.1476-5381.1969.tb08010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Godfraind T., Miller R., Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986 Dec;38(4):321–416. [PubMed] [Google Scholar]
  17. Hellestrand K. J., Nathan A. W., Bexton R. S., Camm A. J. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds. Am J Cardiol. 1984 Feb 27;53(5):30B–38B. doi: 10.1016/0002-9149(84)90499-5. [DOI] [PubMed] [Google Scholar]
  18. Holmes B., Heel R. C. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985 Jan;29(1):1–33. doi: 10.2165/00003495-198529010-00001. [DOI] [PubMed] [Google Scholar]
  19. Hudgins P. M., Weiss G. B. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J Pharmacol Exp Ther. 1968 Jan;159(1):91–97. [PubMed] [Google Scholar]
  20. Johansson B., Johsson O., Axelsson J., Wahlström B. Electrical and mechanical characteristics of vascular smooth muscle response to norepinephrine and isoproterenol. Circ Res. 1967 Nov;21(5):619–633. doi: 10.1161/01.res.21.5.619. [DOI] [PubMed] [Google Scholar]
  21. Josephson M. A., Ikeda N., Singh B. N. Effects of flecainide on ventricular function: clinical and experimental correlations. Am J Cardiol. 1984 Feb 27;53(5):95B–100B. doi: 10.1016/0002-9149(84)90510-1. [DOI] [PubMed] [Google Scholar]
  22. Karaki H., Kubota H., Urakawa N. Mobilization of stored calcium for phasic contraction induced by norepinephrine in rabbit aorta. Eur J Pharmacol. 1979 Jun 15;56(3):237–245. doi: 10.1016/0014-2999(79)90176-6. [DOI] [PubMed] [Google Scholar]
  23. Karaki H., Weiss G. B. Alterations in high and low affinity binding of 45Ca in rabbit aortic smooth muscle by norepinephrine and potassium after exposure to lanthanum and low temperature. J Pharmacol Exp Ther. 1979 Oct;211(1):86–92. [PubMed] [Google Scholar]
  24. Nelson M. T., Standen N. B., Brayden J. E., Worley J. F., 3rd Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature. 1988 Nov 24;336(6197):382–385. doi: 10.1038/336382a0. [DOI] [PubMed] [Google Scholar]
  25. Pérez-Vizcaino F., Carrón R., Delpón E., Tamargo J. Effects of (S)-nafenodone, a new antidepressant, in isolated guinea-pig atrial and ventricular muscle fibres. Eur J Pharmacol. 1991 Jun 18;199(1):43–50. doi: 10.1016/0014-2999(91)90635-4. [DOI] [PubMed] [Google Scholar]
  26. Schulze J. J., Knops J. Effects of flecainide on contractile force and electrophysiological parameters in cardiac muscle. Arzneimittelforschung. 1982;32(9):1025–1029. [PubMed] [Google Scholar]
  27. Serruys P. W., Vanhaleweyk G., Van Den Brand M., Verdouw P., Lubsen J., Hugenholtz P. G. The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease. Br J Clin Pharmacol. 1983 Jul;16(1):51–59. doi: 10.1111/j.1365-2125.1983.tb02143.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Silke B., Frais M. A., Verma S. P., Reynolds G. W., Hafizullah M., Kalra P. A., Jackson N. C., Taylor S. H. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction. Br J Clin Pharmacol. 1986 Dec;22(6):707–714. doi: 10.1111/j.1365-2125.1986.tb02961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Somberg J. C., Tepper D. Flecainide: a new antiarrhythmic agent. Am Heart J. 1986 Oct;112(4):808–813. doi: 10.1016/0002-8703(86)90478-3. [DOI] [PubMed] [Google Scholar]
  30. Tamargo J., Tejerina T. Effects of oxodipine on 45Ca movements and contractile responses in vascular smooth muscle. Br J Pharmacol. 1989 Jun;97(2):339–346. doi: 10.1111/j.1476-5381.1989.tb11959.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES